Normal wound repair of human skin involves several well-orchestrated phases, which are overlapping, yet distinct in their own way. This presentation aims to defi ne, identify, and classify scars, irrespective of the etiology, describe the methods available to differentiate the various types of scar, and describe the current management strategies available to prevent scar formation. From our studies we conclude that for a good scar outcome early intervention during the evolution of wound healing is required. Meticulous surgery is also essential. Various interventions could be with drugs, chemicals, growth factors, or ionizing radiation. Future holds for continued research in cellular signals.
INTRODUCTION
Normal wound repair of human skin involves several wellorchestrated phases, which are overlapping, yet distinct in their own way. The initial phases immediately after wounding are coagulation and platelet degranulation. This is responsible for the release of important cytokines and growth factors which function as chemotactic agents. This leads to the recruitment of neutrophils, macrophages, endothelial cells, and fibroblasts to the wound region. This is the inflammatory phase, which is followed by the • To describe the methods available to differentiate the various types of scar. • To describe the current management strategies available to prevent scar formation.
Defi nition of scar
Scar is an abnormal area of collagenization after wound repair as compared with the surrounding tissue. An ideal scar has good texture with normal pigmentation neither depressed nor exuberant without contracture. The healed area should look like the normal surrounding tissue [ Figure 1 ].
Abnormal scars
Hypertrophic scars: [ Figure 2 ]
• Thick fibrous structure.
• Hypercellular matrix.
• Increased collagen expression with myofibroblasts.
These scars occurred due to lack of skin resurfacing and second intention wound healing resulting in Hypertrophic scars.
Keloid: [Figure 3]
• Florid growth of fibroblasts.
• Excessive collagen in the dermal matrix.
• Lesion spreads beyond the margins of the original wound. Over activity of growth factors may be responsible for modulating the components of the skin to form abnormal scarring. [3] 
Components of scar

Differentiation of scars
Scars can be differentiated by water content, histochemical analysis, biochemical studies in cultured fibroblasts, ultrastructural examination, and ultrasound studies.
Water content
Biochemical studies show that there was increased water content in the vertices of scar tissue. As we cut these scars, tissue fluids ooze out, particularly in biopsyperformed specimen. This fact was validated by estimating T1 relaxation studies with Magnetic Resonance Imaging between normal skin and scar tissue. Water content is high clinically and in MRI studies. MRI detects the movement of floating water particles reflected and expressed as relaxation time T1. When there is more water, the T1 (relaxation time) will be longer as seen in the chart.
Histochemistry
By using Vangeison's stain, which is specific for collagen, tissues can be stained. Massive collagen deposition is seen in scars due to the fact that more number of fibroblasts that are present in the matrix secretes more collagen [ Figure 4 ].
Cytokine estimations
• PMN leucocytes secrete the proinflammatory IL6 and IL1 cytokines at the wound site. IL6 and IL 1 are increased in the stage of inflammation. Matrix synthesis, degradation, cell proliferation, and cell recruitment at the wound site 
Biochemical studies on cultured fi broblasts
Fibroblasts from normal skin hypertrophic scar and keloid were cultured in DMEM with 10% fetal calf serum.
[ Figure 5 ] The cultured fibroblasts were visualized for any morphological changes. The rate of proliferation of fibroblasts was estimated by MTT assay.
Quantitative estimation of fi broblast proliferation
Morphology of fibroblasts remains the same. Excessive proliferation rate is seen in keloids and hypertrophic scars.
Type I collagen biosynthesis was studied in normal and keloid fibroblast by immunoblotting with antibody to Type I collagen [ Figure 6 ]. Fibronectin, which is the second important matrix protein expression, was studied by immunofluorescence in normal and keloid fibroblasts with antibody to fibronectin. Fibronectin expression is increased in Keloid fibroblasts compared to normal skin fibroblasts [ Figure 7 ].
Apart from changes in dermal matrix proteins, some changes were observed in the epidermis of keloids compared to normal skin. Keratins were isolated from normal skin hypertrophic scar and keloids, and SDS Page Electrophoresis was carried out, and using marker proteins the molecular weight of Keratins were analyzed [ Figure 8 ].
The immunoblot of keratins [ Figure 9 ] was carried out with isolated keratins from normal skin, hypertrophic scar and keloids with antibody to proliferating type of keratins. From both of the above figures [ Figures 8 and 9 ] the increased quantities of proliferating type of keratin of molecular weight 50 KD is confirmed.
[ Figure 10 ] shows the Ultra structural studies of fibroblast by Electron microscopy. The increased endoplasmic reticulum in keloid fibroblasts signifies increased protein synthesis.
Differentiation of scars by ultrasound studies
High resolution ultrasound scanning [ Figure 11 ] can differentiate scars. The third dimension of spread into the depth of the dermis by collagen fibers can be seen. Keloidal scars have maximum invasion of the depth by the collagen bundles.
Management strategies
• Prevention.
• Pressure garments.
• Surgical excisions and grafting or flap surgery.
• Drug modulation with a low molecular weight heparin and corticosteroids. • Antihistamine. • Ionizing radiation.
• Therapy with decorin.
Closure of the wound at the earliest, will help in preventing scar formation. [4] Meticulous care of the wound with appropriate dressing will not form a bad scar. Avoidance of infection will help early wound closure. Antiinflammatory agents like low molecular weight heparin will enable the wound to heal faster by reducing chronic wound healing phase. Management strategies are directed toward the phases of wound healing, which in turn predicts the scar outcome.
Prevention
Meticulous wound care, excision of devitalized tissue, and the use of proper suture materials gives a good scar. In the case of skin grafting, proper massage with moisturizing creams and Jobst pressure garments to give pressure.
Pressure garments
To reduce the interstitial edema occurring during postburn period treatment can be done by pressure dressings, which can be custom-made after surgery. In the field of plastic and reconstructive surgery, every step, planning, execution, postoperative care, and managing of the scars are very important. [5] [6] [7] Reduction in scar hypertrophy can be achieved by pressure garments, hydrogel therapy, and silicone incorporated pressure dressings. This reduces interstitial edema and induces apoptosis.
Surgical treatment
[ Figure 12 ] shows how treatment is achieved by excision of scar and realignment, skin grafting, and scar therapy.
Inhibition of scar growth with anti-infl ammatory drugs, namely low molecular weight heparin and corticosteroids
Inhibition of scar growth by low molecular weight heparin is through modulation of pro-inflammatory cytokines -IL6.
Heparin protocol
Low molecular weight heparin fragmin is usually used. 
Adult
Biological membrane
Harvested in 2500 I.U. in 500 ml of normal saline with Gentamycin in the regular refrigerator. Used within 12 hours.
Monitoring
Estimation of platelet count should not fall below 50,000. Nitric oxide synthase is increased in acute burns. This is responsible for prolonged inflammatory response and ultimately results in deranged wound healing and scar production. Low molecular heparin effectively reduces the NOS by its anti-NOS activity. This is shown in the two immunohistochemistry pictures where the NOS expression was increased in control and NOS levels decreased in treated cases. Monoclonal antibody for NOS was used for this work [ Figure 13 ].
Treatment with corticosteroids
Long acting synthetic glucocorticoids such as triamcinolone are most commonly used for treatment of hypertrophic and Keloid scars. Solution of triamcinolone is injected in 10-40 mg/ml concentrations into the scar. [8] However, the morbidity of repeated injection on a monthly basis, fat atrophy and the depigmentation of skin are major drawbacks to these treatments. Steroids are often useful for the treatment of older scars that are less metabolically active and also are not routinely used as a scar preventive measure after wound closure.
Effect of antihistamine Avil on cultured fi broblasts [Figure 14]
We investigated the effect of avil (pheniramine maleate) on fibroblasts cultured from keloids and hypertrophic scars. We observed a decrease in the rate of proliferation and total DNA synthesis by keloid fibroblasts in comparison to normal skin fibroblasts. There was also corresponding decrease in the rate of collagen synthesis observed in scar fibroblasts. Hence avil may prove useful in the treatment of keloids and hypertrophic scars. [9] 
Radiotherapy
Radiotherapy after surgical excision of keloids [ Figure 15 ] had shown signs of promise by earlier workers. [10] Low-dose ionizing radiation given within 24 hours following excision of small area of isolated keloid in the earlobe gives 80% success in preventing the recurrence.
Under general anesthesia, keloid was carefully excised and within 24 hrs the patient was sent for radiation. Fifteen Gray electron beam radiation of 1600 RADS were given in 3 divided doses of 5 Gray each (every other day). The long-term results have been very good as we have followed for a period of 1-7 years and found that no case in the group recurred.
To establish the scientific basis for the postoperative radiotherapy, the fibroblasts from excised keloid and normal skin biopsies were isolated and cultured in vitro. Confluent cultures were subjected to 5 Gray gamma radiations for 5 minutes. The proliferations of the irradiated cells were assessed for a period of 5 days. Interestingly the cell proliferation got arrested, but no actual cell death occurred. This clearly shows that irradiation inhibits the growth of dermal fibroblasts but does not kill them leading to prevention of excess matrix production thereby arrest keloid growth. [11] 
Role of decorin [Figure 16]
Non-collagenous matrix proteins, such as proteoglycans are associated with the surface of the collagen fibrils and bring about their proper assembly. Such proteoglycans may sometimes substitute for collagen species at the fibrillar surface or perform auxiliary functions. [12, 13] Some of these contain leucine-rich repeats and have been shown to affect collagen fibrillogenesis and spacing between the mature fibrils. In remodeling phase of wound healing, decorin is an important member of small leucine-rich proteoglycan family. Decorin is indispensable modulator of collagen alignment in wound healing. We have observed that scar fibroblasts have less decorin to normal skin fibroblast. Molecular RNA studies were done in both abnormal scar tissue and cultured fibroblasts. Densitometry was used as a mode of measurement to visualize the intensity of the bands.
[GAPDH] is an enzyme that is constant in normal skin and scars. As its intensity does not change, this was used as a marker.
Immunofl uorescence
Immunofluorescence in fibroblasts was visualized by a fluorescent microscope after instilling the immunofluorescent antibodies to normal skin and keloid fibroblasts. [ Figure 17 ] As the scar fibroblasts have less decorin, the fluorescence is less in keloid tissue when compared to normal skin. [14] Decorin binds with TGFb in the cultured fibroblast and reduces cell proliferation and synthesis of collagen in wound healing. Our study indicates that decorin that appears to be a natural antidote for fibrotic disorders can be exploited for therapeutic intervention. Decorin may be incorporated in reconstituted collagen dressing, but cannot be given to the patient either orally or even directly applied on the burn.
CONCLUSION
For a good scar outcome, early intervention during the evolution of wound healing is required. Meticulous surgery is also essential. Various interventions could be with drugs, chemicals, growth factors, or ionizing radiation. Future holds for continued research in cellular signals.
